ACAN SEC-arkiveringar - AmeriCann, Inc.- Årsredovisning, Fullmaktsutlåtande, prospekt

Grundläggande statistik

CIK

1508348

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to AmeriCann, Inc.

SEC Filings (Chronological Order)

Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.

May 23, 2025	15-12G	OMB APPROVAL OMB APPROVAL OMB Number: 3235-0167 Expires: August 31, 2027 Estimated average burden hours per response 1.
February 14, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (E
January 15, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
January 15, 2025	EX-19	Insider Trading Policies and Procedures EXHIBIT 19 Insider Trading Policy I. PURPOSE AmeriCann, Inc. (the “Company”) has adopted this Insider Trading Policy (this “Policy”) to help its directors and officers comply with insider trading laws, to prevent even the appearance of improper insider trading and to promote compliance with the Company’s obligation under Item 408 of Regulation S-K to publicly disclose information related to its in
December 26, 2024	NT 10-K	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 NT 10-K 1 acan20241226nt10k.htm FORM NT 10-K U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SEC File Number 000-54231 CUSIP Number 030588107 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR For Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 10-Q For the Transi
December 13, 2024	EX-10.18	Real Estate Agreement EXHIBIT 10.18 Certain identified information (shown as “Omitted”) in this exhibit has been excluded from this exhibit pursuant to Item 601(b)(10) of Regulation S-K since the excluded information is not material and would likely cause competitive harm to the Company if publicly disclosed. REAL ESTATE AGREEMENT THIS AGREEMENT is effective as of the 19th day of November, 2024 (the “Effective Date”) b
December 13, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 14, 2024 AMERICANN, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 14, 2024 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File
August 28, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 27, 2024 AMERICANN, INC. (Exact name of Registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File No
August 26, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 23, 2024 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File No
August 12, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (Exact
May 14, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (Exac
May 7, 2024	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 3, 2024 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File No.) (
May 7, 2024	EX-10.16	BASK Mutual Lease Modification Agreement dated May 3, 2024. Exhibit 10.16 MUTUAL LEASE MODIFICATION AGREEMENT THIS MUTUAL LEASE MODIFICATION AGREEMENT (the “Agreement”) is made as of the 3rd of May, 2024 (the “Effective Date”) by and between AmeriCann, Inc., a Colorado corporation with an address of 1555 Blake Street, Unit 502, Denver, CO 80202 (hereinafter the "Landlord") and Bask, Inc., a Massachusetts corporation with an address of 2 Pequod Road, Fairha
February 14, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (E
December 22, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
December 11, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 30, 2023 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
December 11, 2023	EX-10.17	Loan Modification Agreement EXHIBIT 10.17 LOAN MODIFICATION AGREEMENT Reference is hereby made to a certain loan dated August 2, 2019 provided by MA Investor LLC, a Colorado limited liability company, with an address of 18 Inverness Place E, Denver, CO 80112 (the “Lender”) to AmeriCann, Inc., a Colorado corporation with an address of 1555 Blake Street, Unit 502, Denver, CO 80202 (the “Borrower”). R E C I T A L S On August 2,
August 14, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (Exact
August 1, 2023	EX-10.16	Loan Modification Agreement EXHIBIT 10.16 LOAN MODIFICATION AGREEMENT Reference is hereby made to a certain loan dated August 2, 2019 provided by MA Investor LLC, a Colorado limited liability company, with an address of 18 Inverness Place E, Denver, CO 80112 (the “Lender”) to AmeriCann, Inc., a Colorado corporation with an address of 1555 Blake Street, Unit 502, Denver, CO 80202 (the “Borrower”). R E C I T A L S On August 2,
August 1, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 31, 2023 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File No.)
May 11, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (Exac
February 14, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (E
January 9, 2023	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 9, 2023 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer o
January 9, 2023	EX-99	AmeriCann Reports Record Fiscal Year-End and Quarterly Financial Results The Company achieved all-time revenue, record net income and substantial EBITDA growth EX-99 2 ex462190.htm EXHIBIT 99 Exhibit 99 AmeriCann Reports Record Fiscal Year-End and Quarterly Financial Results The Company achieved all-time revenue, record net income and substantial EBITDA growth BOSTON, Jan. 9, 2023 (GLOBE NEWSWIRE) - via InvestorWire - AmeriCann Inc. (OTCQB: ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and dis
December 29, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
August 15, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (Exact
May 16, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (Exac
February 14, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (E
December 8, 2021	EX-99	AmeriCann Reports Record Quarter and Fiscal Year-End Financial Results The Company achieved positive quarterly net income and substantial EBITDA growth Exhibit 99. AmeriCann Reports Record Quarter and Fiscal Year-End Financial Results The Company achieved positive quarterly net income and substantial EBITDA growth BOSTON, Dec. 8, 2021 (GLOBE NEWSWIRE) - via InvestorWire - AmeriCann Inc. (OTCQB: ACAN) (the ?Company?), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, released financia
December 8, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 8, 2021 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
December 6, 2021	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
November 18, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 18, 2021 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File
November 18, 2021	EX-99	AmeriCann Announces a 300% Increase in Annual Revenue The Company Provides an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis Center Exhibit 99 AmeriCann Announces a 300% Increase in Annual Revenue The Company Provides an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis Center BOSTON, Nov.
August 16, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (Exact
July 6, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 6, 2021 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer of i
July 6, 2021	EX-99	AmeriCann Announces Nearly 300% Increase in Quarterly Revenue from Comparable Quarter in 2020 The Company Provided an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis Center Exhibit 99 AmeriCann Announces Nearly 300% Increase in Quarterly Revenue from Comparable Quarter in 2020 The Company Provided an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis Center Boston, MA - July 6, 2021 - AmeriCann, Inc.
May 13, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (Exac
April 6, 2021	EX-99	AmeriCann Announces Record Breaking Quarterly Revenue The Company Provided an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis Center Exhibit 99 AmeriCann Announces Record Breaking Quarterly Revenue The Company Provided an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis Center Boston, MA - April 6, 2021 - AmeriCann, Inc.
April 6, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 6, 2021 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File No.)
February 19, 2021	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 18, 2021 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
February 16, 2021	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC (E
February 11, 2021	8-K	Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 11, 2021 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
February 11, 2021	EX-99	AmeriCann Launches Successful National Brand 1906 at its Massachusetts Cannabis Center 1906 “Drops” product released to excellent reviews and strong sales Exhibit 99 AmeriCann Launches Successful National Brand 1906 at its Massachusetts Cannabis Center 1906 “Drops” product released to excellent reviews and strong sales BOSTON, MA / ACCESSWIRE / February 11, 2021 / AmeriCann, Inc.
February 5, 2021	8-K	Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 5, 2021 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
December 21, 2020	10-K	Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
November 20, 2020	8-K	Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 20, 2020 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
October 6, 2020	EX-99	AmeriCann Nearly Doubles Quarterly Revenue Company Benefits from Increased Production/Sales at its Flagship Massachusetts Cannabis Center Exhibit 99 AmeriCann Nearly Doubles Quarterly Revenue Company Benefits from Increased Production/Sales at its Flagship Massachusetts Cannabis Center Boston, MA - October 6, 2020 - AmeriCann, Inc.
October 6, 2020	8-K	Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 6, 2020 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer o
August 12, 2020	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (Exact
May 14, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (Exac
April 21, 2020	EX-99	Building 2 Design Exhibit 99
April 21, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 21, 2020 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer of
February 27, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 27, 2020 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File
February 24, 2020	EX-99	AmeriCann Announces Record Quarterly Net Income in Excess of $1,000,000 for its First Quarter Fiscal Year 2020 Results Expects its Massachusetts Cannabis Center Building 1 to Commence Operations by End of March 2020 Exhibit 99 AmeriCann Announces Record Quarterly Net Income in Excess of $1,000,000 for its First Quarter Fiscal Year 2020 Results Expects its Massachusetts Cannabis Center Building 1 to Commence Operations by End of March 2020 Denver, CO – Accesswire – February 24, 2020 - AmeriCann, Inc.
February 24, 2020	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 24, 2020 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
February 19, 2020	10-Q	ACAN / Americann Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (E
February 10, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 10, 2020 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
January 28, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 27, 2020 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
January 14, 2020	10-K	ACAN / Americann Inc. 10-K - Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
November 25, 2019	EX-99	November 22, 2019 Exhibit 99 FOR IMMEDIATE RELEASE November 22, 2019 AmeriCann Comments on Massachusetts’ First Year of Adult-Use Cannabis Sales Company is positioned to benefit from participating in one of the nation’s strongest marijuana markets DENVER, CO / ACCESSWIRE / November 21, 2019 / AmeriCann, Inc.
November 25, 2019	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 25, 2019 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
October 15, 2019	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 14, 2019 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
October 10, 2019	EX-10.14	Promissory Note (5) EXHIBIT 10.14 PROMISSORY NOTE U.S. $4,000,000.00 August 2, 2019 FOR VALUE RECEIVED, and at the times hereinafter specified, AMERICANN, INC., a Colorado corporation (“Borrower”), whose address is 1550 Wewatta Street, Denver, Colorado 80202, hereby promises to pay to the order of MA INVESTOR, LLC, a Colorado limited liability company (hereinafter referred to, together with each subsequent holder her
October 10, 2019	S-1/A	ACAN / Americann Inc. S-1/A - - FORM S-1/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Amendment No. 1 Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Primary Standard Classi- fication Code Number) (IRS Employer I.D. Number) 1550 Wewatta St. Denver, CO 80202 (303) 86
October 10, 2019	EX-4.11	Form of Series XI Warrant (5) EXHIBIT 4.11 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES XI This Warrant to Purchase Common Stock (this “Warrant”) is to certify that, FOR VALUE RECEIVED, MA Investor, LLC, a Colorado limited liability company (with its permitted assigns, the “Holder”), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc., a Delaware corporation (the “Company”), 600,
October 10, 2019	EX-4.12	Form of Series XII Warrant (5) EXHIBIT 4.12 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES XII This Warrant to Purchase Common Stock (this “Warrant”) is to certify that, FOR VALUE RECEIVED, (with its permitted assigns, the “Holder”), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc., a Delaware corporation (the “Company”), shares of the common stock of the Company (“Common Stock”)
October 10, 2019	EX-10.15	Mortgage and Security Agreement (5) EXHIBIT 10.15 Recording requested by: And when recorded mail to: Otten, Johnson, Robinson, Neff & Ragonetti, P.C. 950 Seventeenth Street Suite 1600 Denver, Colorado 80202 Attention: Kevin A. Gliwa, Esq. MORTGAGE, SECURITY AGREEMENT, FIXTURE FILING, FINANCING STATEMENT AND ASSIGNMENT OF LEASES AND RENTS THIS MORTGAGE, SECURITY AGREEMENT, FIXTURE FILING, FINANCING STATEMENT AND ASSIGNMENT OF LEASES
October 7, 2019	EX-99	Operations Update Exhibit 99
October 7, 2019	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 7, 2019 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer o
September 27, 2019	EX-4.11	Form of Series XI Warrant EXHIBIT 4.11 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES XI This Warrant to Purchase Common Stock (this “Warrant”) is to certify that, FOR VALUE RECEIVED, MA Investor, LLC, a Colorado limited liability company (with its permitted assigns, the “Holder”), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc., a Delaware corporation (the “Company”), 600,
September 27, 2019	S-1	ACAN / Americann Inc. S-1 - Registration Statement - FORM S-1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Primary Standard Classi- fication Code Number) (IRS Employer I.D. Number) 1550 Wewatta St. Denver, CO 80202 (303) 862-9000 (Address,
September 27, 2019	EX-4.12	Form of Series XII Warrant EXHIBIT 4.12 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES XII This Warrant to Purchase Common Stock (this “Warrant”) is to certify that, FOR VALUE RECEIVED, (with its permitted assigns, the “Holder”), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc., a Delaware corporation (the “Company”), shares of the common stock of the Company (“Common Stock”)
September 27, 2019	EX-10.14	Promissory Note EXHIBIT 10.14 PROMISSORY NOTE U.S. $4,000,000.00 August 2, 2019 FOR VALUE RECEIVED, and at the times hereinafter specified, AMERICANN, INC., a Colorado corporation (“Borrower”), whose address is 1550 Wewatta Street, Denver, Colorado 80202, hereby promises to pay to the order of MA INVESTOR, LLC, a Colorado limited liability company (hereinafter referred to, together with each subsequent holder her
September 27, 2019	EX-10.15	Mortgage and Security Agreement EXHIBIT 10.15 Recording requested by: And when recorded mail to: Otten, Johnson, Robinson, Neff & Ragonetti, P.C. 950 Seventeenth Street Suite 1600 Denver, Colorado 80202 Attention: Kevin A. Gliwa, Esq. MORTGAGE, SECURITY AGREEMENT, FIXTURE FILING, FINANCING STATEMENT AND ASSIGNMENT OF LEASES AND RENTS THIS MORTGAGE, SECURITY AGREEMENT, FIXTURE FILING, FINANCING STATEMENT AND ASSIGNMENT OF LEASES
August 19, 2019	10-Q	ACAN / Americann Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (E
August 8, 2019	EX-99	Site plan for Building 2 Exhibit 99
August 8, 2019	8-K	Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 2, 2019 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer of
July 23, 2019	POS AM	ACAN / Americann Inc. POS AM - - FORM POS AM File #: 333-227388 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Post-Effective Amendment No. 1 Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Primary Standard Classi- fication Code Number) (IRS Employer I.D. Number) 1550 Wew
July 1, 2019	POS AM	ACAN / Americann Inc. POS AM - - FORM POS AM File #: 333-224256 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Post-Effective Amendment No. 1 Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Primary Standard Classi- (IRS Employer of incorporation) fication Code Number) I.D. Number) 1550 Wew
June 13, 2019	424B3	AMERICANN, INC Common Stock 424(b)((3) File # 333-222207 PROSPECTUS AMERICANN, INC Common Stock This prospectus may be used only in connection with sales of shares of our common stock by Mountain States Capital, LLC.
May 30, 2019	POS AM	ACAN / Americann Inc. POS AM - - FORM POS AM SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Post-Effective Amendment No. 1 Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Primary Standard Classi- (IRS Employer of incorporation) fication Code Number) I.D. Number) 1550 Wewatta St. Denver, CO
May 20, 2019	10-Q	ACAN / Americann Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (
February 21, 2019	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 7, 2019 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
February 21, 2019	EX-99	AmeriCann Enters into a Joint Venture Which Will Operate in the Fast Growing Massachusetts Cannabis Market Joint Venture will provide Revenue Participation For AmeriCann at Flagship Massachusetts Medical Cannabis Center Building 1 Construction is on EXHIBIT 99 FOR IMMEDIATE RELEASE February 21, 2019 AmeriCann Enters into a Joint Venture Which Will Operate in the Fast Growing Massachusetts Cannabis Market Joint Venture will provide Revenue Participation For AmeriCann at Flagship Massachusetts Medical Cannabis Center Building 1 Construction is on Schedule for Completion in Summer 2019 (Denver, CO)—AmeriCann, Inc.
February 19, 2019	10-Q	ACAN / Americann Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, IN
January 30, 2019	EX-99	Company Tops Off Building 1 of its Flagship Massachusetts Medical Cannabis Center EXHIBIT 99 FOR IMMEDIATE RELEASE January 30, 2019 AmeriCann Achieves Construction Milestone on its Massachusetts Cannabis Cultivation and Processing Development Company Tops Off Building 1 of its Flagship Massachusetts Medical Cannabis Center (Denver, CO)—AmeriCann, Inc.
January 30, 2019	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 30, 2019 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
January 17, 2019	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 17, 2019 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer
January 17, 2019	EX-99	Power Point Presentation Exhibit 99
January 15, 2019	10-K	ACAN / Americann Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
September 24, 2018	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2018 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer of
September 24, 2018	EX-99	Building 2 of MMCC Schematic Site Plan Exhibit 99
September 17, 2018	S-1	ACAN / Americann Inc. FORM S-1 As filed with the Securities and Exchange Commission on September 18, 2018 SECURITIES AND EXCHANGE COMMISSION Washington, D.
September 17, 2018	EX-4.9	Form of Series IX Warrant (4) EXHIBIT 4.9 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES IX This is to certify that, FOR VALUE RECEIVED, , or registered assigns (“Holder”), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the “Company”), shares of the common stock of the Company (“Common Stock”). This Warrant may be exercised at a purchase price of $1.00 per share at any time o
September 17, 2018	EX-4.10	Form of Series X Warrant (4) EXHIBIT 4.10 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES X This is to certify that, FOR VALUE RECEIVED, , or registered assigns (“Holder”), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the “Company”), shares of the common stock of the Company (“Common Stock”). This Warrant may be exercised at a purchase price of $1.00 per share at any time o
August 17, 2018	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 6, 2018 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer of
August 14, 2018	10-Q	ACAN / Americann Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (E
July 17, 2018	8-K	Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 10, 2018 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer of
May 15, 2018	10-Q	ACAN / Americann Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (
May 4, 2018	S-1/A	ACAN / Americann Inc. FORM S-1/A As filed with the Securities and Exchange Commission on , 2018 SECURITIES AND EXCHANGE COMMISSION Washington, D.
May 4, 2018	EX-10.13	Third Amendment to Ground Lease (3) EXHIBIT 10.13 AMENDMENT TO GROUND LEASE 1. The Parties agree that the third and fourth sentences of Section 9.2 of the Ground Lease entered into as of October 17, 2016 by and between Massachusetts Medical Properties LLC (“MMP”) and AmeriCann, Inc. (“AmeriCann”) are amended to read as follows: “Tenant will have until twenty (20) months from the Commencement Date to raise the $2.6 million dollars, r
April 24, 2018	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 24, 2018 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File No.) (IRS Employer of
April 24, 2018	EX-99	Exhibit 99 Exhibit 99
April 12, 2018	EX-4.7	Form of Series VIII Warrant (3) EXHIBIT 4.7 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES VIII This is to certify that, FOR VALUE RECEIVED, , or registered assigns (“Holder”), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the “Company”), shares of the common stock of the Company (“Common Stock”). This Warrant may be exercised at a purchase price of $1.50 per share at any time
April 12, 2018	EX-10.12	Second Amendment to Ground Lease (3) EX-10.12 5 ex110074.htm EXHIBIT 10.12 EXHIBIT 10.12 AMENDMENT TO GROUND LEASE 1. The Parties agree that the third and fourth sentences of Section 9.2 of the Ground Lease entered into as of October 17, 2016 by and between Massachusetts Medical Properties LLC (“MMP”) and AmeriCann, Inc. (“AmeriCann”) are amended to read as follows: “Tenant will have until eighteen (18) months from the Commencement D
April 12, 2018	EX-10.11	Form of Convertible Note (February 2018 financing) (3) EXHIBIT 10.11 AMERICANN, INC. 8% UNSECURED CONVERTIBLE PROMISSORY NOTE FOR VALUE RECEIVED, AmeriCann, Inc., a Delaware corporation, and its successors and assigns, (the "Company") promises to pay to the order of (the "Holder"), the principal sum of $ in lawful money of the United States of America, together with interest on so much of the principal balance thereof as is from time to time outstandi
April 12, 2018	S-1	ACAN / Americann Inc. FORM S-1 As filed with the Securities and Exchange Commission on , 2018 SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 20, 2018	10-Q	ACAN / Americann Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, IN
February 14, 2018	EX-10.6	Amendment to Ground Lease (2) EXHIBIT 10.6 AMENDMENT TO GROUND LEASE 1. The Parties agree that the third and fourth sentences of Section 9.2 of the Ground Lease entered into as of October 17, 2016 by and between Massachusetts Medical Properties LLC (?MMP?) and AmeriCann, Inc. (?AmeriCann?) are amended to read as follows: ?Tenant will have until sixteen (16) months from the Commencement Date to raise the $2.6 million dollars, r
February 14, 2018	S-1/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Registration Statement Under THE SECURITIES ACT OF 1933 acan2017093010k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Primary Standard Classi- (IRS Employer of incorporation) fication Code Number) I.D. Number) 1550 Wawetta St. Denver, CO 80202 (3
February 14, 2018	EX-4.2	Form of Series II Warrant (2) EXHIBIT 4.2 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES II This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), 25,000 shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $0.75 per share at any
February 14, 2018	EX-3.12	Certificate of Ownership and Merger (name change to AmeriCann) (2) Exhibit 3.1.2 EXHIBITS AMERICANN, INC. REGISTRATION STATEMENT ON FORM S-1 EXHIBIT 3.1.2 State of Delaware Secretary of State Division of Corporations Delivered 11:51 AM 02/27/2014 FILED 11:51 AM 02/27/2014 SRV 140257422 - 4341319 FILE CERTIFICATE OF OWNERSHIP AND MERGER Nevada Health Scan, Inc. (a Delaware Corporation) AND ACS Merger Corporation (a Colorado Corporation) UNDER SECTION 253 OF THE GE
February 14, 2018	EX-10.8	Loan Agreement ($128,000) (2) EXHIBIT 10.8 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of October 5, 2017, by and between AMERICANN, INC., a Delaware corporation, with its address at 3200 Brighton Blvd. Unit 114, Denver, CO 80216 (the ?Company?), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the
February 14, 2018	EX-10.2	Loan Modification Agreement with Strategic Capital Partners, LLC, together with Warrants and Promissory Notes (2) EXHIBIT 10.2 AMERICANN, INC. LOAN MODIFICATION AGREEMENT The parties agree as follows: 1. As of July 14, 2016 AmeriCann, Inc. owed Strategic Capital Partners, LLC (?SCP?) $2,431,646. 2. SCP agrees to convert $500,000 of the amount owed into 400,000 shares of the restricted common stock of AmeriCann. 3. In connection with the conversion, AmeriCann will issue SCP warrants to purchase 800,000 shares
February 14, 2018	EX-10.10	Form of Convertible Note EXHIBIT 10.10 AMERICANN, INC. 8% UNSECURED CONVERTIBLE PROMISSORY NOTE FOR VALUE RECEIVED, AmeriCann, Inc., a Delaware corporation, and its successors and assigns, (the "Company") promises to pay to the order of (the "Holder"), the principal sum of $ in lawful money of the United States of America, together with interest on so much of the principal balance thereof as is from time to time outstandi
February 14, 2018	EX-4.1	Form of Series I Warrant (2) EXHIBIT 4.1 AMERICANN, INC. SERIES I WARRANT This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is the holder of Series I Warrants of AmeriCann, Inc. (the ?Company?). Each Warrant allows the holder to purchase one share of the Company?s Common Stock at a price of $3.00 per share. The number of shares of Common Stock to be received upon the exercise of this Warrant, and
February 14, 2018	EX-4.6	Form of Series VII Warrant EXHIBIT 4.6 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES VII This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), shares of the common stock of the Company (?Common Stock?). This Warrant may be exercised at a purchase price of $1.50 per share at any time
February 14, 2018	EX-10.9	Loan Agreement ($68,000) (2) EXHIBIT 10.9 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of November 13, 2017, by and between AMERICANN, INC., a Delaware corporation, with its address at 3200 Brighton Blvd. Unit 114, Denver, CO 80216 (the ?Company?), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (t
February 14, 2018	EX-10.7	Loan Agreement ($800,000) (2) EXHIBIT 10.7 LOAN AGREEMENT This Agreement is made on October 30, 2017 by and between AmeriCann, Inc. (?AmeriCann?) and James F. Barton, Jr., the Brad W. Opel Revocable Trust and the JTO Irrevocable Trust (collectively the ?Lenders?). 1. The Lenders agree to lend AmeriCann $800,000. The loan will be funded on October 30, 2017 and will be evidenced by a promissory note (the ?Note?) in the form atta
February 14, 2018	EX-4.4	Form of Series V Warrant (2) EXHIBIT 4.4 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES V This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $5.00 per share at any time pri
February 14, 2018	EX-3.2	Bylaws (2) EXHIBIT 3.2 BYLAWS OF AMERICANN, INC. ARTICLE I OFFICES Section l. Offices: The principal office of the Corporation shall be determined by the Board of Directors, and the Corporation shall have other offices at such places as the Board of Directors may from time to time determine. ARTICLE II STOCKHOLDER'S MEETINGS Section l. Place: The place of stockholders' meetings shall be the principal office
February 14, 2018	EX-4.5	Form of Series VI Warrant EXHIBIT 4.5 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES VI This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), shares of the common stock of the Company (?Common Stock?). This Warrant may be exercised at a purchase price of $1.50 per share at any time o
February 14, 2018	EX-10.4	Share Purchase Agreement with Massachusetts Medical Properties, LLC, together with Warrant (Series IV) and Ground Lease (2) EXHIBIT 10.4 SHARE PURCHASE AGREEMENT This Share Purchase Agreement, dated as of October 17, 2016 (this ?Agreement?), is entered into by and between AmeriCann, Inc., a Delaware corporation (the ?Company?), and Massachusetts Medical Properties, LLC, a Delaware limited liability company (the ?Purchaser?). WHEREAS, the Company is party to that certain Purchase and Sale Agreement , dated as of January
February 14, 2018	EX-10.1	Agreements with Wellness Group Pharms (2) EXHIBIT 10.1 LOAN AGREEMENT This Loan Agreement (this ?Agreement?), is made as of September 21, 2014 between: 1. AmeriCann, Inc. (?AmeriCann?) and 2. Wellness Group Pharms, LLC (?WGP?). INTRODUCTION WGP has requested that AmeriCann extend credit to WGP in the form of loan not to exceed $4,760,000 to be used to fund WGP?s acquisition, development and construction of property, plant, equipment, all
February 14, 2018	EX-10.3	Agreements with Coastal Compassion, Inc. (2) EXHIBIT 10.3 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the "Agreement") is made and entered into the 7th day of April, 2016 (the "Effective Date") by and between Coastal Compassion, Inc., a Massachusetts non-profit organization with an address at 36 N. Water Street, Unit 2, New Bedford, MA 02740 (hereinafter ?Company"), and AmeriCann, Inc., a Delaware corporation with an address at 3200 Brig
February 14, 2018	EX-4.3	Form of Series III Warrant (2) EXHIBIT 4.3 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES III This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), 25,000 shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $1.25 per share at any
February 14, 2018	EX-10.5	Investment Agreement with Mountain States Capital, LLC (2) EXHIBIT 10.5 INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (the ?Agreement?), dated as of December 12, 2017 (the ?Execution Date?), is entered into by and between AmeriCann, Inc. (the ?Company?), and Mountain States Capital, LLC (the ?Investor?). RECITALS: WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to Ten Million D
February 2, 2018	EX-10.1	Agreements with Wellness Group Pharms (2) EXHIBIT 10.1 LOAN AGREEMENT This Loan Agreement (this ?Agreement?), is made as of September 21, 2014 between: 1. AmeriCann, Inc. (?AmeriCann?) and 2. Wellness Group Pharms, LLC (?WGP?). INTRODUCTION WGP has requested that AmeriCann extend credit to WGP in the form of loan not to exceed $4,760,000 to be used to fund WGP?s acquisition, development and construction of property, plant, equipment, all
February 2, 2018	EX-10.9	Loan Agreement ($68,000) (2) EX-10.9 19 ex103871.htm EXHIBIT 10.9 EXHIBIT 10.9 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 13, 2017, by and between AMERICANN, INC., a Delaware corporation, with its address at 3200 Brighton Blvd. Unit 114, Denver, CO 80216 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Roa
February 2, 2018	EX-10.6	First Amendment to Ground Lease (2) EXHIBIT 10.6 AMENDMENT TO GROUND LEASE 1. The Parties agree that the third and fourth sentences of Section 9.2 of the Ground Lease entered into as of October 17, 2016 by and between Massachusetts Medical Properties LLC (?MMP?) and AmeriCann, Inc. (?AmeriCann?) are amended to read as follows: ?Tenant will have until sixteen (16) months from the Commencement Date to raise the $2.6 million dollars, r
February 2, 2018	EX-4.5	Form of Series VI Warrant (2) EXHIBIT 4.5 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES VI This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), shares of the common stock of the Company (?Common Stock?). This Warrant may be exercised at a purchase price of $1.50 per share at any time o
February 2, 2018	EX-3.12	Certificate of Ownership and Merger (name change to AmeriCann) (2) Exhibit 3.1.2 EXHIBITS AMERICANN, INC. REGISTRATION STATEMENT ON FORM S-1 EXHIBIT 3.1.2 State of Delaware Secretary of State Division of Corporations Delivered 11:51 AM 02/27/2014 FILED 11:51 AM 02/27/2014 SRV 140257422 - 4341319 FILE CERTIFICATE OF OWNERSHIP AND MERGER Nevada Health Scan, Inc. (a Delaware Corporation) AND ACS Merger Corporation (a Colorado Corporation) UNDER SECTION 253 OF THE GE
February 2, 2018	EX-4.6	Form of Series VII Warrant (2) EXHIBIT 4.6 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES VII This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?), is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), shares of the common stock of the Company (?Common Stock?). This Warrant may be exercised at a purchase price of $1.50 per share at any time
February 2, 2018	EX-3.2	Bylaws (2) EXHIBIT 3.2 BYLAWS OF AMERICANN, INC. ARTICLE I OFFICES Section l. Offices: The principal office of the Corporation shall be determined by the Board of Directors, and the Corporation shall have other offices at such places as the Board of Directors may from time to time determine. ARTICLE II STOCKHOLDER'S MEETINGS Section l. Place: The place of stockholders' meetings shall be the principal office
February 2, 2018	EX-4.4	Form of Series V Warrant (2) EXHIBIT 4.4 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES V This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $5.00 per share at any time pri
February 2, 2018	EX-10.2	Loan Modification Agreement with Strategic Capital Partners, LLC, together with Warrants and Promissory Notes (2) EXHIBIT 10.2 AMERICANN, INC. LOAN MODIFICATION AGREEMENT The parties agree as follows: 1. As of July 14, 2016 AmeriCann, Inc. owed Strategic Capital Partners, LLC (?SCP?) $2,431,646. 2. SCP agrees to convert $500,000 of the amount owed into 400,000 shares of the restricted common stock of AmeriCann. 3. In connection with the conversion, AmeriCann will issue SCP warrants to purchase 800,000 shares
February 2, 2018	EX-4.1	Form of Series I Warrant (2) EXHIBIT 4.1 AMERICANN, INC. SERIES I WARRANT This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is the holder of Series I Warrants of AmeriCann, Inc. (the ?Company?). Each Warrant allows the holder to purchase one share of the Company?s Common Stock at a price of $3.00 per share. The number of shares of Common Stock to be received upon the exercise of this Warrant, and
February 2, 2018	EX-4.3	Form of Series III Warrant (2) EXHIBIT 4.3 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES III This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), 25,000 shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $1.25 per share at any
February 2, 2018	EX-10.4	Share Purchase Agreement with Massachusetts Medical Properties, LLC, together with Warrant (Series IV) and Ground Lease (2) EXHIBIT 10.4 SHARE PURCHASE AGREEMENT This Share Purchase Agreement, dated as of October 17, 2016 (this ?Agreement?), is entered into by and between AmeriCann, Inc., a Delaware corporation (the ?Company?), and Massachusetts Medical Properties, LLC, a Delaware limited liability company (the ?Purchaser?). WHEREAS, the Company is party to that certain Purchase and Sale Agreement , dated as of January
February 2, 2018	EX-10.5	Investment Agreement with Mountain States Capital, LLC (2) EXHIBIT 10.5 INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (the ?Agreement?), dated as of December 12, 2017 (the ?Execution Date?), is entered into by and between AmeriCann, Inc. (the ?Company?), and Mountain States Capital, LLC (the ?Investor?). RECITALS: WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to Ten Million D
February 2, 2018	EX-10.8	Loan Agreement ($128,000) (2) EXHIBIT 10.8 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of October 5, 2017, by and between AMERICANN, INC., a Delaware corporation, with its address at 3200 Brighton Blvd. Unit 114, Denver, CO 80216 (the ?Company?), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the
February 2, 2018	EX-10.7	Loan Agreement, including form of warrant (Series CL) ($800,000) (2) EXHIBIT 10.7 LOAN AGREEMENT This Agreement is made on October 30, 2017 by and between AmeriCann, Inc. (?AmeriCann?) and James F. Barton, Jr., the Brad W. Opel Revocable Trust and the JTO Irrevocable Trust (collectively the ?Lenders?). 1. The Lenders agree to lend AmeriCann $800,000. The loan will be funded on October 30, 2017 and will be evidenced by a promissory note (the ?Note?) in the form atta
February 2, 2018	EX-10.3	Agreements with Coastal Compassion, Inc. (2) EXHIBIT 10.3 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the "Agreement") is made and entered into the 7th day of April, 2016 (the "Effective Date") by and between Coastal Compassion, Inc., a Massachusetts non-profit organization with an address at 36 N. Water Street, Unit 2, New Bedford, MA 02740 (hereinafter ?Company"), and AmeriCann, Inc., a Delaware corporation with an address at 3200 Brig
February 2, 2018	EX-10.10	Form of Convertible Note (December 2017 financing) (2) EXHIBIT 10.10 AMERICANN, INC. 8% UNSECURED CONVERTIBLE PROMISSORY NOTE FOR VALUE RECEIVED, AmeriCann, Inc., a Delaware corporation, and its successors and assigns, (the "Company") promises to pay to the order of (the "Holder"), the principal sum of $ in lawful money of the United States of America, together with interest on so much of the principal balance thereof as is from time to time outstandi
February 2, 2018	S-1/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Registration Statement Under THE SECURITIES ACT OF 1933 acan2017093010k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Primary Standard Classi- (IRS Employer of incorporation) fication Code Number) I.D. Number) 3200 Brighton Blvd., Unit 144 Denver
February 2, 2018	EX-4.2	Form of Series II Warrant (2) EXHIBIT 4.2 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES II This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), 25,000 shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $0.75 per share at any
December 21, 2017	EX-4.3	Form of Series III Warrant EXHIBIT 4.3 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES III This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), 25,000 shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $1.25 per share at any
December 21, 2017	S-1	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Registration Statement Under THE SECURITIES ACT OF 1933 As filed with the Securities and Exchange Commission on , 2017 SECURITIES AND EXCHANGE COMMISSION Washington, D.
December 21, 2017	EX-10.8	Loan Agreement ($128,000) EXHIBIT 10.8 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of October 5, 2017, by and between AMERICANN, INC., a Delaware corporation, with its address at 3200 Brighton Blvd. Unit 114, Denver, CO 80216 (the ?Company?), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the
December 21, 2017	EX-3.2	AMERICANN, INC. ARTICLE I EXHIBIT 3.2 BYLAWS OF AMERICANN, INC. ARTICLE I OFFICES Section l. Offices: The principal office of the Corporation shall be determined by the Board of Directors, and the Corporation shall have other offices at such places as the Board of Directors may from time to time determine. ARTICLE II STOCKHOLDER'S MEETINGS Section l. Place: The place of stockholders' meetings shall be the principal office
December 21, 2017	EX-10.6	Amendment to Ground Lease EXHIBIT 10.6 AMENDMENT TO GROUND LEASE 1. The Parties agree that the third and fourth sentences of Section 9.2 of the Ground Lease entered into as of October 17, 2016 by and between Massachusetts Medical Properties LLC (?MMP?) and AmeriCann, Inc. (?AmeriCann?) are amended to read as follows: ?Tenant will have until sixteen (16) months from the Commencement Date to raise the $2.6 million dollars, r
December 21, 2017	EX-10.5	Investment Agreement with Mountain States Capital, LLC EXHIBIT 10.5 INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (the ?Agreement?), dated as of December 12, 2017 (the ?Execution Date?), is entered into by and between AmeriCann, Inc. (the ?Company?), and Mountain States Capital, LLC (the ?Investor?). RECITALS: WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to Ten Million D
December 21, 2017	EX-4.1	Form of Series I Warrant EXHIBIT 4.1 AMERICANN, INC. SERIES I WARRANT This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is the holder of Series I Warrants of AmeriCann, Inc. (the ?Company?). Each Warrant allows the holder to purchase one share of the Company?s Common Stock at a price of $3.00 per share. The number of shares of Common Stock to be received upon the exercise of this Warrant, and
December 21, 2017	EX-4.2	Form of Series II Warrant EXHIBIT 4.2 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES II This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), 25,000 shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $0.75 per share at any
December 21, 2017	EX-4.4	Form of Series V Warrant EXHIBIT 4.4 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES V This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $5.00 per share at any time pri
December 21, 2017	EX-10.3	Agreements with Coastal Compassion, Inc. EXHIBIT 10.3 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the "Agreement") is made and entered into the 7th day of April, 2016 (the "Effective Date") by and between Coastal Compassion, Inc., a Massachusetts non-profit organization with an address at 36 N. Water Street, Unit 2, New Bedford, MA 02740 (hereinafter ?Company"), and AmeriCann, Inc., a Delaware corporation with an address at 3200 Brig
December 21, 2017	EX-10.1	Agreements with Wellness Group Pharms EXHIBIT 10.1 LOAN AGREEMENT This Loan Agreement (this ?Agreement?), is made as of September 21, 2014 between: 1. AmeriCann, Inc. (?AmeriCann?) and 2. Wellness Group Pharms, LLC (?WGP?). INTRODUCTION WGP has requested that AmeriCann extend credit to WGP in the form of loan not to exceed $4,760,000 to be used to fund WGP?s acquisition, development and construction of property, plant, equipment, all
December 21, 2017	EX-10.7	Loan Agreement ($800,000) EXHIBIT 10.7 LOAN AGREEMENT This Agreement is made on October 30, 2017 by and between AmeriCann, Inc. (?AmeriCann?) and James F. Barton, Jr., the Brad W. Opel Revocable Trust and the JTO Irrevocable Trust (collectively the ?Lenders?). 1. The Lenders agree to lend AmeriCann $800,000. The loan will be funded on October 30, 2017 and will be evidenced by a promissory note (the ?Note?) in the form atta
December 21, 2017	EX-10.2	Loan Modification Agreement with Strategic Capital Partners, LLC, together with Warrants and Promissory Notes EXHIBIT 10.2 AMERICANN, INC. LOAN MODIFICATION AGREEMENT The parties agree as follows: 1. As of July 14, 2016 AmeriCann, Inc. owed Strategic Capital Partners, LLC (?SCP?) $2,431,646. 2. SCP agrees to convert $500,000 of the amount owed into 400,000 shares of the restricted common stock of AmeriCann. 3. In connection with the conversion, AmeriCann will issue SCP warrants to purchase 800,000 shares
December 21, 2017	EX-10.4	Share Purchase Agreement with Massachusetts Medical Properties, LLC, together with Warrant (Series IV) and Ground Lease EXHIBIT 10.4 SHARE PURCHASE AGREEMENT This Share Purchase Agreement, dated as of October 17, 2016 (this ?Agreement?), is entered into by and between AmeriCann, Inc., a Delaware corporation (the ?Company?), and Massachusetts Medical Properties, LLC, a Delaware limited liability company (the ?Purchaser?). WHEREAS, the Company is party to that certain Purchase and Sale Agreement , dated as of January
December 21, 2017	EX-3.12	Certificate of Ownership and Merger (name change to AmeriCann) Exhibit 3.1.2 EXHIBITS AMERICANN, INC. REGISTRATION STATEMENT ON FORM S-1 EXHIBIT 3.1.2 State of Delaware Secretary of State Division of Corporations Delivered 11:51 AM 02/27/2014 FILED 11:51 AM 02/27/2014 SRV 140257422 - 4341319 FILE CERTIFICATE OF OWNERSHIP AND MERGER Nevada Health Scan, Inc. (a Delaware Corporation) AND ACS Merger Corporation (a Colorado Corporation) UNDER SECTION 253 OF THE GE
December 21, 2017	EX-10.9	Loan Agreement ($68,000) EXHIBIT 10.9 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of November 13, 2017, by and between AMERICANN, INC., a Delaware corporation, with its address at 3200 Brighton Blvd. Unit 114, Denver, CO 80216 (the ?Company?), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (t
December 4, 2017	EX-10.2	Real Estate Contract with EEN Real Estate, Inc. (filed herewith) Exhibit 10.2
December 4, 2017	EX-3.12	Certificate of Ownership and Merger (Name Change) (filed herewith) Exhibit 3.1.2 State of Delaware Secretary of State Division of Corporations Delivered 11:51 AM 02/27/2014 FILED 11:51 AM 02/27/2014 SRV 140257422 - 4341319 FILE CERTIFICATE OF OWNERSHIP AND MERGER Nevada Health Scan, Inc. (a Delaware Corporation) AND ACS Merger Corporation (a Colorado Corporation) UNDER SECTION 253 OF THE GENERAL CORPORATION LAW OF THE STATE OF DELAWARE The undersigned corporation
December 4, 2017	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
November 9, 2017	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant acan201711098k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 5, 2017 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File N
September 7, 2017	8-K	Financial Statements and Exhibits acan201709068k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 1, 2017 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File
September 7, 2017	EX-10.7	Investment Agreement with Mountain States Capital, LLC ex10-7.htm EXHIBIT 10.7 INVESTMENT AGREEMENT This INVESTMENT AGREEMENT (the ?Agreement?), dated as of September 1, 2017 (the ?Execution Date?), is entered into by and between AmeriCann, Inc. (the ?Company?), and Mountain States Capital, LLC (the ?Investor?). RECITALS: WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to Te
September 7, 2017	EX-99.1	AMERicannSecures $10,000,000 Equity Financing Commitment ex99-1.htm Exhibit 99.1 AMERicannSecures $10,000,000 Equity Financing Commitment Proceeds Will be Used to Develop the Company?s State-of-the-art Massachusetts Medical Cannabis Center in Freetown, Massachusetts DENVER, CO / September 7, 2017 / AmeriCann, Inc. (OTCQX: ACAN), an Agricultural-Technology company that is developingthe next generation of sustainable, state-of-the-art medical cannabis cul
August 14, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q acan2017063010q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-359
June 7, 2017	8-K	Other Events acan201706068k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 5, 2017 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Co
May 15, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q acan2017033110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35
March 21, 2017	8-K	Current Report acan201703208k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 15, 2017 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (
March 2, 2017	EX-4.1	AMERICANN, INC. SERIES I WARRANT EXHIBIT 4.1 AMERICANN, INC. SERIES I WARRANT This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is the holder of Series I Warrants of AmeriCann, Inc. (the ?Company?). Each Warrant allows the holder to purchase one share of the Company?s Common Stock at a price of $3.00 per share. The number of shares of Common Stock to be received upon the exercise of this Warrant, and
March 2, 2017	EX-10.2	LOAN AGREEMENT EXHIBIT 10.2 LOAN AGREEMENT This Loan Agreement (this ?Agreement?), is made as of September 21, 2014 between: 1. AmeriCann, Inc. (?AmeriCann?) and 2. Wellness Group Pharms, LLC (?WGP?). INTRODUCTION WGP has requested that AmeriCann extend credit to WGP in the form of loan not to exceed $4,760,000 to be used to fund WGP?s acquisition, development and construction of property, plant, equipment, all
March 2, 2017	EX-10.3	AMERICANN, INC. LOAN MODIFICATION AGREEMENT EXHIBIT 10.3 AMERICANN, INC. LOAN MODIFICATION AGREEMENT The parties agree as follows: 1. As of July 14, 2016 AmeriCann, Inc. owed Strategic Capital Partners, LLC (?SCP?) $2,431,646. 2. SCP agrees to convert $500,000 of the amount owed into 400,000 shares of the restricted common stock of AmeriCann. 3. In connection with the conversion, AmeriCann will issue SCP warrants to purchase 800,000 shares
March 2, 2017	EX-10.1	EMPLOYMENT AGREEMENT EXHIBIT 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (?Agreement?) is entered into as of March 25, 2014, by and between Americann, Inc. (formerly named Nevada Health Scan, Inc.), a Delaware corporation (?NHS?), AmeriCann, Inc., a Colorado corporation (?AmeriCann,? and along with NHS, the ?Companies?) and Timothy R. Keogh, (?Employee?). In consideration of the mutual promises and conditions
March 2, 2017	EX-10.6	SHARE PURCHASE AGREEMENT EXHIBIT 10.6 SHARE PURCHASE AGREEMENT This Share Purchase Agreement, dated as of October 17, 2016 (this ?Agreement?), is entered into by and between AmeriCann, Inc., a Delaware corporation (the ?Company?), and Massachusetts Medical Properties, LLC, a Delaware limited liability company (the ?Purchaser?). WHEREAS, the Company is party to that certain Purchase and Sale Agreement , dated as of January
March 2, 2017	S-1	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) acan20170208s1.htm As filed with the Securities and Exchange Commission on , 2017 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Registration Statement Under THE SECURITIES ACT OF 1933 AMERICANN, INC. (Exact name of registrant as specified in charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Primary Standard Classi- fication Code Number) (IR
March 2, 2017	EX-4.2	AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES II EXHIBIT 4.2 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES II This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), 25,000 shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $0.75 per share at any
March 2, 2017	EX-4.3	AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES III EXHIBIT 4.3 AMERICANN, INC. WARRANT TO PURCHASE COMMON STOCK SERIES III This is to certify that, FOR VALUE RECEIVED, , or registered assigns (?Holder?) is entitled to purchase, subject to the provisions of this Warrant, from AmeriCann, Inc. (the ?Company?), 25,000 shares of the common stock of the Company (?Common Stock?). This warrant may be exercised at a purchase price of $1.25 per share at any
March 2, 2017	EX-10.5	CONSULTING AGREEMENT EXHIBIT 10.5 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the "Agreement") is made and entered into the 7th day of April, 2016 (the "Effective Date") by and between Coastal Compassion, Inc., a Massachusetts non-profit organization with an address at 36 N. Water Street, Unit 2, New Bedford, MA 02740 (hereinafter ?Company"), and AmeriCann, Inc., a Delaware corporation with an address at 3200 Brig
March 2, 2017	EX-10.4	THIRD AMENDMENT TO CONSULTING AGREEMENT EXHIBIT 10.4 THIRD AMENDMENT TO CONSULTING AGREEMENT THIS THIRD AMENDMENT TO CONSULTING AGREEMENT is entered into effective as of May 1, 2015, by and between Nature?s Own Wellness Center, a Colorado limited liability company, having its usual place of business at 4900 Jackson Street, Denver, Colorado 80216 and 4900 Jackson, LLC a Colorado limited liability company, having its usual place of busine
March 2, 2017	EX-3.2	AMERICANN, INC. ARTICLE I EXHIBIT 3.2 BYLAWS OF AMERICANN, INC. ARTICLE I OFFICES Section l. Offices: The principal office of the Corporation shall be determined by the Board of Directors, and the Corporation shall have other offices at such places as the Board of Directors may from time to time determine. ARTICLE II STOCKHOLDER'S MEETINGS Section l. Place: The place of stockholders' meetings shall be the principal office
February 16, 2017	8-K	Financial Statements and Exhibits, Other Events acan201702158k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 16, 2017 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation
February 16, 2017	EX-99.1	AmeriCann CEO to Present at Boston University’s Questrom School of Business Beyond Stigma: Envisioning the Cannabis Marketplace in Massachusetts is Scheduled for Wednesday, February 22 in Boston ex99-1.htm Exhibit 99.1 AmeriCann CEO to Present at Boston University?s Questrom School of Business Beyond Stigma: Envisioning the Cannabis Marketplace in Massachusetts is Scheduled for Wednesday, February 22 in Boston DENVER, CO / Accesswire / February 16, 2017 / AmeriCann, Inc. (OTCQX: ACAN), a company that is developing sustainable, state-of-the-art medical cannabis cultivation properties, anno
February 16, 2017	EX-99.2	EX-99.2 EX-99.2 3 ex99-2.htm EXHIBIT 99.2 Exhibit 99.2
February 14, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q acan2016123110q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001
January 12, 2017	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K acan2016083010k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2016 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICA
November 8, 2016	8-K	Unregistered Sales of Equity Securities acan201611088k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 7, 2016 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission File
October 19, 2016	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets acan201610198k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 17, 2016 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation)
October 19, 2016	EX-99	EX-99 ex99.htm Exhibit 99
September 20, 2016	EX-99	AmeriCann Launches “Solanna” Line of Cannabis Infused Products The Solanna Brand is the Latest Addition to the Company’s Expanding Intellectual Property Portfolio ex99.htm EXHIBIT 99 AmeriCann Launches ?Solanna? Line of Cannabis Infused Products The Solanna Brand is the Latest Addition to the Company?s Expanding Intellectual Property Portfolio DENVER, CO / September 21, 2016 / AmeriCann, Inc. (ACAN-OTCQX), a company that designs and plans to develop sustainable, state-of-the-art medical cannabis cultivation properties, has announced the creation of ?Solanna
September 20, 2016	8-K	Financial Statements and Exhibits acan201609208k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 15, 2016 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction (Commission Fil
August 12, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (E
June 22, 2016	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 15, 2016 AMERICANN, INC. (Exact name of registrant as specified in its charter) Delaware 000-54231 27-4336843 (State or other jurisdiction of incorporation) (Commission File No.)
June 22, 2016	EX-99	MASSACHUSETTS MEDICAL CANNABIS CENTER $5 MILLION SECURED CONVERTIBLE NOTES JUNE 2016 This presentation has been prepared by the company and includes information from other sources believed by management to be reliable. No representation or warranty, Exhibit 99 MASSACHUSETTS MEDICAL CANNABIS CENTER $5 MILLION SECURED CONVERTIBLE NOTES JUNE 2016 This presentation has been prepared by the company and includes information from other sources believed by management to be reliable.
May 10, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (Exac
February 16, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (E
January 13, 2016	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
January 13, 2016	EX-3.1.2	Certificate of Ownership and Merger (name change to AmeriCann, Inc.) Exhibit 3.1.2 CERTIFICATE OF OWNERSHIP AND MERGER Nevada Health Scan, Inc. (a Delaware Corporation) AND ACS Merger Corporation (a Colorado Corporation) UNDER SECTION 253 OF THE GENERAL CORPORATION LAW OF THE STATE OF DELAWARE The undersigned corporations do hereby certify: FIRST: That the name and state of incorporation of each of the constituent corporations of the merger are as follows: NAME STA
August 18, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35902 AMERICANN, INC (Exact
July 21, 2015	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the quarterly period ended June 30, 2014 o Transition Repo UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the quarterly period ended June 30, 2014 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the transition period from to Commission File Number: 000-54231 AMERICANN, INC
February 18, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54231 AMERICANN, INC. (Exact name
August 14, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the quarterly period ended June 30, 2014 o Transition Report Under Section UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the quarterly period ended June 30, 2014 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the transition period from to Commission File Number: 000-54231 AMERICANN, INC (Exact name of
August 8, 2014	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the quarterly period ended March 31, 2014 o Transition Rep UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment #1 x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the quarterly period ended March 31, 2014 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the transition period from to Commission File Number: 000-54231 AMERICANN, IN
February 19, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the quarterly period ended December 31, 2013 o Transition Report Under Sec UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the quarterly period ended December 31, 2013 o Transition Report Under Section 13 or 15(d) of the Securities Exchange Act Of 1934 For the transition period from to Commission File Number: 000-54231 NEVADA HEALTH SCAN, INC. (
January 22, 2014	10-Q/A	Americann FORM 10Q/A (Quarterly Report) U UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q AMENDMENT NO. 1 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013 COMMISSION FILE NUMBER: 000-54231 NEVADA HEALTH SCAN, INC. (Exact Name of Registrant as Specified in its Charter) DELAWARE 27-4336843 (State of Incorporation) (I.R.S.
January 21, 2014	10-Q/A	Americann FORM 10Q/A (Quarterly Report) U UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q AMENDMENT NO. 1 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2012 COMMISSION FILE NUMBER: 000-54231 NEVADA HEALTH SCAN, INC. (Exact Name of Registrant as Specified in its Charter) DELAWARE 27-4336843 (State of Incorporation) (I.R
January 21, 2014	10-Q/A	Americann FORM 10-Q/A (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q AMENDMENT NO. 1 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013 COMMISSION FILE NUMBER: 000-54231 NEVADA HEALTH SCAN, INC. (Exact Name of Registrant as Specified in its Charter) DELAWARE 27-4336843 (State of Incorporation) (I.R.S. E
December 30, 2013	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-54231 NEVADA HEALTH SCAN, INC. (Exact name of registrant as s
November 19, 2013	8-K/A	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8-K/A Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
November 19, 2013	EX-16	November 7, 2013 Converted by EDGARwiz November 7, 2013 U.S. Securities and Exchange Commission Office of the Chief Accountant 100F Street Northeast Washington, DC 20549-2000 RE: Nevada Health Scan, Inc. File No. 000-54231 Dear Sir or Madam: We have read Item 4.01 of the first Form 8-K filed Nevada Health Scan, Inc. (“the Registrant’) and responded with our letter at that time dated October 25, 2013. We note that
October 30, 2013	8-K	Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8K Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
October 30, 2013	EX-16.1	October 25, 2013 Converted by EDGARwiz October 25, 2013 U.S. Securities and Exchange Commission Office of the Chief Accountant 100F Street Northeast Washington, DC 20549-2000 RE: Nevada Health Scan, Inc. File No. 000-54231 Dear Sir or Madam: We have read Item 4.01 of Form 8-K dated October 25, 2013 of Nevada Health Scan, Inc. and disagree with the statements contained therein as it pertains to our firm. We did not
August 14, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013 COMMISSION FILE NUMBER: 000-54231 N UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013 COMMISSION FILE NUMBER: 000-54231 NEVADA HEALTH SCAN, INC. (Exact Name of Registrant as Specified in its Charter) DELAWARE 27-4336843 (State of Incorporation) (I.R.S. Employer ID Number
May 14, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013 COMMISSION FILE NUMBER: 000-54231 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2013 COMMISSION FILE NUMBER: 000-54231 NEVADA HEALTH SCAN, INC. (Exact Name of Registrant as Specified in its Charter) DELAWARE 27-4336843 (State of Incorporation) (I.R.S. Employer ID Numbe
February 14, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2012 COMMISSION FILE NUMBER: 000-542 10-Q 1 nevadahealth215201310q.htm FORM 10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2012 COMMISSION FILE NUMBER: 000-54231 NEVADA HEALTH SCAN, INC. (Exact Name of Registrant as Specified in its Charter) DELAWARE 27-4336843 (Sta
March 21, 2011	15-12G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-54231 Nevada Health Scan, Inc. (Exact name of registrant as specified in
March 9, 2011	10-12G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-A AMENDMENT NUMBER 3 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NEVADA HEALTH SCAN, INC. (Exact na UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-A AMENDMENT NUMBER 3 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NEVADA HEALTH SCAN, INC. (Exact name of registrant as specified in its charter) Delaware 27-4336843 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Iden
March 8, 2011	CORRESP	Nevada Health Scan, Inc. 16459 Pauhaska Place Apple Valley, California 92307 Nevada Health Scan, Inc. 16459 Pauhaska Place Apple Valley, California 92307 March 7, 2011 Jennifer Gowetski Senior Counsel U.S. Securities & Exchange Commission Washington, DC 20549 Re: Nevada Health Scan, Inc. Form 10-12G Dear Ms. Gowetski: In response to your letter dated March 3, 2011 we have added a paragraph on page 11 containing the requested disclosure. The Company further acknowledges tha
February 23, 2011	10-12G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-A AMENDMENT NUMBER 2 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NEVADA HEALTH SCAN, INC. (Exact na 10-A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-A AMENDMENT NUMBER 2 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NEVADA HEALTH SCAN, INC. (Exact name of registrant as specified in its charter) Delaware 27-4336843 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer
February 22, 2011	CORRESP	Nevada Health Scan, Inc. 16459 Pauhaska Place Apple Valley, California 92307 Nevada Health Scan, Inc. 16459 Pauhaska Place Apple Valley, California 92307 February 21, 2011 Jennifer Gowetski Senior Counsel U.S. Securities & Exchange Commission Washington, DC 20549 Re: Nevada Health Scan, Inc. Form 10-12G Dear Ms. Gowetski: In response to your letter dated February 17, 2011, we reply below using your comment numbers. 1. The revised disclosure was made on page 2 of the redlin
February 7, 2011	10-12G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-A AMENDMENT NUMBER 1 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NEVADA HEALTH SCAN, INC. (Exact na UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-A AMENDMENT NUMBER 1 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NEVADA HEALTH SCAN, INC. (Exact name of registrant as specified in its charter) Delaware 27-4336843 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Iden
February 7, 2011	CORRESP	Nevada Health Scan, Inc. 16459 Pauhaska Place Apple Valley, California 92307 Nevada Health Scan, Inc. 16459 Pauhaska Place Apple Valley, California 92307 February 2, 2011 Jennifer Gowetski Senior Counsel U.S. Securities & Exchange Commission Washington, DC 20549 Re: Nevada Health Scan, Inc. Form 10-12G Dear Ms. Gowetski: In response to your letter dated January 20, 2011, we reply below using your comment numbers. 1. We are filing herewith our amended Form 10. 2. The error
December 23, 2010	EX-3	CORPORATE BY-LAWS NEVADA HEALTH SCAN, INC. EX-3 3 nevada10122210ex32.htm EX-3 BYLAWS EXHIBIT 3.2 CORPORATE BY-LAWS OF NEVADA HEALTH SCAN, INC. OFFICES I - The registered office of the corporation shall be in the State of Delaware. The resident agent in charge thereof shall be appointed by the Board of Directors. The corporation may also have offices at such other places both within and without the State of Delaware as the Board of Director
December 23, 2010	EX-4	NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “E” WARRANT CERTIFICATE WARRANT NUMBER _______ NUMBER OF WARRANTS: ______________ CLASS “E” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN MEDIA, INC. THESE S EXHIBIT 4.5 EXHIBIT 4.5 NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “E” WARRANT CERTIFICATE WARRANT NUMBER NUMBER OF WARRANTS: CLASS “E” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN MEDIA, INC. THESE SECURITIES WERE ISSUED EXEMPT FROM REGISTRATION UNDER TITLE 11, SECTION 1145, OF THE U.S. CODE. FOR VALUE RECEIVED, Nevada Health Scan, Inc. (the "Com
December 23, 2010	EX-4	NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “A” WARRANT CERTIFICATE WARRANT NUMBER _______ NUMBER OF WARRANTS: ______________ CLASS “A” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN, INC. THESE SECURIT EXHIBIT 4.1 NEVADA HEALTH SCAN, INC. (A Delaware Corporation) ?A? WARRANT CERTIFICATE WARRANT NUMBER NUMBER OF WARRANTS: CLASS ?A? WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN, INC. THESE SECURITIES WERE ISSUED EXEMPT FROM REGISTRATION UNDER TITLE 11, SECTION 1145, OF THE U.S. CODE. FOR VALUE RECEIVED, Nevada Health Scan, Inc. (the "Company"), a Delaware
December 23, 2010	EX-4	NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “D” WARRANT CERTIFICATE WARRANT NUMBER _______ NUMBER OF WARRANTS: ______________ CLASS “D” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN, INC. THESE SECURIT EXHIBIT 4.4 EXHIBIT 4.4 NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “D” WARRANT CERTIFICATE WARRANT NUMBER NUMBER OF WARRANTS: CLASS “D” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN, INC. THESE SECURITIES WERE ISSUED EXEMPT FROM REGISTRATION UNDER TITLE 11, SECTION 1145, OF THE U.S. CODE. FOR VALUE RECEIVED, Nevada Health Scan, Inc. (the "Company")
December 23, 2010	EX-4	NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “B” WARRANT CERTIFICATE WARRANT NUMBER _______ NUMBER OF WARRANTS: ______________ CLASS “B” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN, INC. THESE SECURIT EX-4 5 nevada10122210ex42.htm EX-4.2 FORM OF ???B??? WARRANT AGREEMENT EXHIBIT 4.2 NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “B” WARRANT CERTIFICATE WARRANT NUMBER NUMBER OF WARRANTS: CLASS “B” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN, INC. THESE SECURITIES WERE ISSUED EXEMPT FROM REGISTRATION UNDER TITLE 11, SECTION 1145, OF THE U.S. CODE. F
December 23, 2010	10-12G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NEVADA HEALTH SCAN, INC. (Exact name of registrant as s UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NEVADA HEALTH SCAN, INC. (Exact name of registrant as specified in its charter) Delaware 27-4336843 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 16459
December 23, 2010	EX-3	Certificate of Incorporation (1) EXHIBIT 3.1 State of Delaware Secretary of State Division of Corporations Delivered 04:36 PM 06/25/2010 FILED 04:36 PM 06/25/2010 SRV 100693027 – 4841319 FILE Certificate Of Incorporation Of Nevada Health Scan, Inc. FIRST: The name of the corporation shall be: Nevada Health Scan, Inc. SECOND: The address of its registered office in the State of Delaware is 1201 Orange Street, Suite 600 in the City
December 23, 2010	EX-4	NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “C” WARRANT CERTIFICATE WARRANT NUMBER _______ NUMBER OF WARRANTS: ______________ CLASS “C” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN, INC. THESE SECURIT EX-4 6 nevada10122210ex43.htm EX-4.3 FORM OF ???C??? WARRANT AGREEMENT EXHIBIT 4.3 NEVADA HEALTH SCAN, INC. (A Delaware Corporation) “C” WARRANT CERTIFICATE WARRANT NUMBER NUMBER OF WARRANTS: CLASS “C” WARRANT CERTIFICATE FOR THE PURCHASE OF SHARES OF THE COMMON STOCK OF NEVADA HEALTH SCAN, INC. THESE SECURITIES WERE ISSUED EXEMPT FROM REGISTRATION UNDER TITLE 11, SECTION 1145, OF THE U.S. CODE. F

ACAN / AmeriCann, Inc. - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

Grundläggande statistik

SEC Filings

SEC Filings (Chronological Order)